These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19897763)

  • 61. Determinants of medication adherence to antihypertensive medications among a Chinese population using Morisky Medication Adherence Scale.
    Lee GK; Wang HH; Liu KQ; Cheung Y; Morisky DE; Wong MC
    PLoS One; 2013; 8(4):e62775. PubMed ID: 23638143
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antihypertensive prescriptions over a 10-year period in a large Chinese population.
    Wong MC; Tam WW; Cheung CS; Tong EL; Sek AC; Cheung NT; Yan BP; Yu CM; Griffiths SM
    Am J Hypertens; 2013 Jul; 26(7):931-8. PubMed ID: 23591987
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality.
    Fosbøl EL; Butt JH; Østergaard L; Andersson C; Selmer C; Kragholm K; Schou M; Phelps M; Gislason GH; Gerds TA; Torp-Pedersen C; Køber L
    JAMA; 2020 Jul; 324(2):168-177. PubMed ID: 32558877
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Angiotensin-Receptor Blocker, Angiotensin-Converting Enzyme Inhibitor, and Risks of Atrial Fibrillation: A Nationwide Cohort Study.
    Hsieh YC; Hung CY; Li CH; Liao YC; Huang JL; Lin CH; Wu TJ
    Medicine (Baltimore); 2016 May; 95(20):e3721. PubMed ID: 27196491
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A Retrospective Study from 2 Centers in China on the Effects of Continued Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients with Hypertension and COVID-19.
    Wang Z; Zhang D; Wang S; Jin Y; Huan J; Wu Y; Xia C; Li Z; Qi X; Zhang D; Han X; Zhu X; Qu Y; Wang Q
    Med Sci Monit; 2020 Sep; 26():e926651. PubMed ID: 32969367
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Post-stroke pneumonia prevention by angiotensin-converting enzyme inhibitors: results of a meta-analysis of five studies in Asians.
    Shinohara Y; Origasa H
    Adv Ther; 2012 Oct; 29(10):900-12. PubMed ID: 22983755
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care.
    Mazzaglia G; Mantovani LG; Sturkenboom MC; Filippi A; Trifirò G; Cricelli C; Brignoli O; Caputi AP
    J Hypertens; 2005 Nov; 23(11):2093-100. PubMed ID: 16208153
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Adherence with antihypertensive drug therapy and the risk of heart failure in clinical practice.
    Corrao G; Rea F; Ghirardi A; Soranna D; Merlino L; Mancia G
    Hypertension; 2015 Oct; 66(4):742-9. PubMed ID: 26222709
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy.
    Patel BV; Remigio-Baker RA; Thiebaud P; Preblick R; Plauschinat C
    BMC Fam Pract; 2008 Nov; 9():61. PubMed ID: 18990240
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Persistence with Antihypertensive Medications in Uncomplicated Treatment-Naïve Patients: Effects of Initial Therapeutic Classes.
    Ah YM; Lee JY; Choi YJ; Kim B; Choi KH; Kong J; Oh JM; Shin WG; Lee HY
    J Korean Med Sci; 2015 Dec; 30(12):1800-6. PubMed ID: 26713055
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The association between medication adherence and treatment intensification with blood pressure control in resistant hypertension.
    Daugherty SL; Powers JD; Magid DJ; Masoudi FA; Margolis KL; O'Connor PJ; Schmittdiel JA; Ho PM
    Hypertension; 2012 Aug; 60(2):303-9. PubMed ID: 22733464
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Relationships between Medication Adherence and Cardiovascular Disease Risk Factor Control in Elderly Patients with Diabetes.
    Raebel MA; Dyer W; Nichols GA; Goodrich GK; Schmittdiel JA
    Pharmacotherapy; 2017 Oct; 37(10):1204-1214. PubMed ID: 28752555
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Meta-analysis: impact of drug class on adherence to antihypertensives.
    Kronish IM; Woodward M; Sergie Z; Ogedegbe G; Falzon L; Mann DM
    Circulation; 2011 Apr; 123(15):1611-21. PubMed ID: 21464050
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Primary hyperaldosteronism among Chinese hypertensive patients: how are we doing in a local district in Hong Kong.
    Sy WM; Fu SN; Luk W; Wong CK; Fung LM
    Hong Kong Med J; 2012 Jun; 18(3):193-200. PubMed ID: 22665682
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Relationship Between Medication Adherence and Distance to Dispensing Pharmacies and Prescribers Among an Urban Medicaid Population with Diabetes Mellitus.
    Syed ST; Sharp LK; Kim Y; Jentleson A; Lora CM; Touchette DR; Berbaum ML; Suda KJ; Gerber BS
    Pharmacotherapy; 2016 Jun; 36(6):590-7. PubMed ID: 27087250
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Association of Changes in Medication Use and Adherence With Accountable Care Organization Exposure in Patients With Cardiovascular Disease or Diabetes.
    McWilliams JM; Najafzadeh M; Shrank WH; Polinski JM
    JAMA Cardiol; 2017 Sep; 2(9):1019-1023. PubMed ID: 28700790
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The use of renin-angiotensin-aldosterone system (RAAS) inhibitors is associated with a lower risk of mortality in hypertensive COVID-19 patients: A systematic review and meta-analysis.
    Wang Y; Chen B; Li Y; Zhang L; Wang Y; Yang S; Xiao X; Qin Q
    J Med Virol; 2021 Mar; 93(3):1370-1377. PubMed ID: 33095513
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical and nonclinical correlates of adherence to prescribing guidelines for hypertension in a large managed care organization.
    Skelding PC; Majumdar SR; Kleinman K; Warner C; Salem-Schatz S; Miroshnik I; Prosser L; Simon SR
    J Clin Hypertens (Greenwich); 2006 Jun; 8(6):414-9. PubMed ID: 16760680
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Combination antihypertensive therapy among patients with COPD.
    Herrin MA; Feemster LC; Crothers K; Uman JE; Bryson CL; Au DH
    Chest; 2013 May; 143(5):1312-1320. PubMed ID: 23287970
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Initial treatment of hypertension and adherence to therapy in general practice in Italy.
    Poluzzi E; Strahinja P; Vargiu A; Chiabrando G; Silvani MC; Motola D; Sangiorgi Cellini G; Vaccheri A; De Ponti F; Montanaro N
    Eur J Clin Pharmacol; 2005 Sep; 61(8):603-9. PubMed ID: 16082539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.